G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method

被引:54
作者
Choi, SH [1 ]
Park, TG [1 ]
机构
[1] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea
关键词
rhG-CSF; biodegradable; PLGA; nanoparticles; sustained release;
D O I
10.1016/j.ijpharm.2005.12.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A new formulation method was developed for preparing poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles loaded with recombinant human granulocyte colony-stimulating factor (rhG-CSF). Lyophilized rhG-CSF powder and PLGA polymer were directly co-dissolved in a single organic phase, and the resulting solution was dispersed into an aqueous Solution. PLGA nanoparticles encapsulating rhG-CSF were produced by a spontaneous emulsion/solvent diffusion method. In this manner, rhG-CSF was molecularly dissolved in the polymer phase. Release profile of rhG-CSF from PLGA nanoparticles was compared with those from two kinds of PLGA microparticles which were separately prepared by either single oil-in-water (O/W) or double water-in-oil-in-water (W/O/W) emulsion technique. The sizes of rhG-CSF loaded nanoparticles, O/W microparticles, and W/O/W microparticles were about 257 nm, 4.7 mu m, and 4.3 mu m, respectively. For rhG-CSF nanoparticles,about 90% of encapsulated rhG-CSF was released out in a sustained manner from PLGA nanoparticles over a 1 week period, but for rhG-CSF microparticles, only about 20% of rhG-CSF Could be released out during the same period. Reversed phase and size exclusion chromatograms revealed that the structural integrity of released rhG-CSF from nanoparticles was nearly intact, compared to that of native rhG-CSF. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 29 条
[1]   Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[2]   COMMUNICATION TO THE EDITOR ON PROTEIN SOLUBILITY IN ORGANIC-SOLVENTS [J].
CHIN, JT ;
WHEELER, SL ;
KLIBANOV, AM .
BIOTECHNOLOGY AND BIOENGINEERING, 1994, 44 (01) :140-145
[3]   PEGylation of G-CSF using cleavable oligo-lactic acid linkage [J].
Choi, SH ;
Lee, H ;
Park, TG .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (02) :271-284
[4]  
CLELAND JL, 1994, ACS SYM SER, V567, P1
[5]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[6]   Stability and release of bovine serum albumin encapsulated within poly(D,L-lactide-co-glycolide) microparticles [J].
Crotts, G ;
Park, TG .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (2-3) :123-134
[7]   Gastrointestinal uptake of biodegradable microparticles: Effect of particle size [J].
Desai, MP ;
Labhasetwar, V ;
Amidon, GL ;
Levy, RJ .
PHARMACEUTICAL RESEARCH, 1996, 13 (12) :1838-1845
[8]   Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs [J].
Dong, YC ;
Feng, SS .
BIOMATERIALS, 2004, 25 (14) :2843-2849
[9]   Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres [J].
Fu, K ;
Pack, DW ;
Klibanov, AM ;
Langer, R .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :100-106
[10]   Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF) [J].
Gibaud, S ;
Rousseau, C ;
Weingarten, C ;
Favier, R ;
Douay, L ;
Andreux, JP ;
Couvreur, P .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) :131-139